Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Blueprint Medicines Corp (NQ: BPMC )

81.93 USD UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Jul 26, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 81.93
Bid (Size) 80.50 (10)
Ask (Size) 85.44 (1)
Prev. Close 81.93
Today's Range 81.93 - 81.93
52wk Range 66.20 - 125.61
Shares Outstanding 58,341,527
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Blueprint Medicines to Report Second Quarter 2021 Financial Results on Thursday, July 29, 2021
Blueprint Medicines Corporation (NASDAQ: BPMC), today announced that it will host a live conference call and webcast at 8:30 a.m. ET on Thursday, July 29, 2021 to report its second quarter 2021... 
From PR Newswire
Blueprint Medicines Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Blueprint Medicines Corporation (NASDAQ: BPMC), a precision therapy company focused on genomically defined cancers, rare diseases and cancer immunotherapy, today announced that, effective on July 1,... 
From PR Newswire

Performance

YTD
-21.65%
-21.65%
1 Month
-7.26%
-7.26%
3 Month
-18.88%
-18.88%
6 Month
-20.38%
-20.38%
1 Year
+8.14%
+8.14%

More News

Read More
FDA Approves Blueprint Medicines' AYVAKIT™ (avapritinib) for the Treatment of Adults with Advanced Systemic Mastocytosis
From PR Newswire
Blueprint Medicines Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
From PR Newswire
Blueprint Medicines to Present at Upcoming Investor Conferences
From PR Newswire
Blueprint Medicines Presents ARROW Trial Data for GAVRETO® (pralsetinib) Highlighting Durable Clinical Activity in Patients with Metastatic RET Fusion-Positive Non-Small Cell Lung Cancer and Other Adv
From PR Newswire
Blueprint Medicines Appoints Percy Carter, MBA, Ph.D., as Chief Scientific Officer
From PR Newswire
Blueprint Medicines Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
From PR Newswire
3 Biotech Stocks Ready for Big Breakthroughs Like Biogen
Tags MYOV BPMC NASDAQ:BIIB,NASDAQ:PRVB,NYSE:MYOV,NASDAQ:BPMC
From InvestorPlace
First Week of BPMC August 20th Options Trading
Tags Stocks
From Market News Video
Analyst Ratings for Blueprint Medicines
Tags Analyst Ratings BPMC BZI/AAR
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.